Security key
249845504
Dermata Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DRMA)
CUSIP: 249845504
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 26,892
- Total 13F value
- $62,390
- Share change
- -65,340
- SEC-reported price per share
- $2.32
- Number of holders
- 7
- Value change
- -$372,054
- Number of buys
- 5
- Number of sells
- 2
- Shares outstanding
- 4,270,578
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
7
Top holders
7
DRMA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Dermata Therapeutics, Inc. SEC filings
Dermata Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 249845504
Recent filing periods:
Ownership snapshot
Top reported holders of DRMA - Dermata Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PROEHL GERALD T
Disclosed value leader
PROEHL GERALD T
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
13F
Lead comparable stake: 13%
13D/G row: PROEHL GERALD T
Showing 1-6 of 15 holder rows.
Quick read
PROEHL GERALD T leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PROEHL GERALD T's linked filing trail.
Comparable ownership
Top 5
PROEHL GERALD T
13%
BIGGER CAPITAL FUND L P
9.9%
ARMISTICE CAPITAL, LLC
5%
VANGUARD GROUP INC
16%
CITADEL ADVISORS LLC
9.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PROEHL GERALD T |
13D/G
|
13%
|
$619,155
804,098 shares
|
$0 | 27 Mar 2025 |
| BIGGER CAPITAL FUND L P |
13D/G
Bigger Michael
|
9.9%
|
$89,401
300,103 shares
|
+$30,551 | 31 Dec 2025 |
| ARMISTICE CAPITAL, LLC |
13F
13D/G
Company
|
5%
from 13D/G
|
$409,903
81,654 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
16%
|
$349,941
476,110 shares
|
— | 30 Sep 2025 |
| CITADEL ADVISORS LLC |
13F
Company
|
9.4%
|
$209,041
284,371 shares
|
— | 30 Sep 2025 |
| BNP PARIBAS FINANCIAL MARKETS |
13F
Company
|
1.7%
|
$36,848
50,127 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
26,892
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
5
Q4 2025 holders
7
Holder diff
2
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend